Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
复制标题
新型非核苷逆转录酶抑制剂 (RTI) 与 AZT 相结合,可产生针对多重 RTI 耐药 HIV-1 菌株的强协同作用
DOI:
10.3390/molecules23071599
复制
发表时间:
2018-07-02
期刊:
影响因子:
--
通讯作者:
Jiang S
中科院分区:
文献类型:
--
作者:
Yu F;Li W;Wang L;Dai Y;Lu X;Wang Q;Xie L;Jiang S
Reverse transcriptase inhibitors (RTIs), including nucleoside RTIs (NRTIs) and non-nucleoside RTIs (NNRTIs), are critical antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infection. Emergence of multi-RTI resistance calls for the development of more potent therapeutics or regimens against RTI-resistant strains. Here, we demonstrated that combining azidothymidine (AZT) with a new NNRTIs under development, diarylpyridine (DAPA)-2e, diarylanilin (DAAN)-14h, or DAAN-15h, resulted in strong synergism against infection by divergent HIV-1 strains, including those resistant to NRTIs and NNRTIs, suggesting the potential for developing these novel NNRTIs as salvage therapy for HIV/acquired immune deficiency syndrome (AIDS) patients.
登录
查看更多内容
影响因子:
7.3
作者:
Liu, Na;Wei, Lei;Huang, Li;Yu, Fei;Zheng, Weifan;Qin, Bingjie;Zhu, Dong-Qin;Morris-Natschke, Susan L.;Jiang, Shibo;Chen, Chin-Ho;Lee, Kuo-Hsiung;Xie, Lan
通讯作者:
Xie, Lan
影响因子:
13.2
作者:
Qi Q;Wang Q;Chen W;Du L;Dimitrov DS;Lu L;Jiang S
通讯作者:
Jiang S
影响因子:
4.9
作者:
Maga, C;Hübscher, U;Spadari, S
通讯作者:
Spadari, S
影响因子:
3.8
作者:
Su, Shan;Wang, Qian;Lu, Lu
通讯作者:
Lu, Lu
影响因子:
2.7
作者:
Tian, Xingtao;Qin, Bingjie;Lu, Hong;Lai, Weihong;Jiang, Shibo;Lee, Kuo-Hsiung;Chen, Chin Ho;Xie, Lan
通讯作者:
Xie, Lan